Company / PP&E per Share
Johnson & Johnson PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$9.05
FY2025
5-year range
$6.73 / $9.05
FY2021-FY2025
Trend
+17.5%
vs FY2024
Sector context
#9 of 193
Health Care
What the data says
Among 193 Health Care companies, Johnson & Johnson is in the top 5% for pp&e per share. PP&E per Share has increased for 3 consecutive years, from $6.73 in FY2022 to $9.05 in FY2025.
Based on SEC 10-K filings.
9.05 in FY2025 with a 5-year CAGR of +5.6%. Top quartile in the Health Care sector.
Improved from $7.44 to $9.05 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +5.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 193This company $9.05 Sector average $22.13
▼
-59.1% below sector average
Key checks
Key Insights
- Johnson & Johnson's pp&e per share has grown for 3 consecutive years.
- In FY2025, pp&e per share increased 17.5% year-over-year.
- Ranks #9 out of 193 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.05 | +17.5% |
| FY2024 | $7.70 | +3.5% |
| FY2023 | $7.44 | +10.5% |
| FY2022 | $6.73 | -4.7% |
| FY2021 | $7.06 | +2.7% |
| FY2020 | $6.88 | +6.9% |
| FY2019 | $6.43 | +5.3% |
| FY2018 | $6.11 | +1.0% |
| FY2017 | $6.05 | +8.8% |
| FY2016 | $5.56 | +0.5% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026